| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de0f9ab36a3e65a9cc11284b7f0d4134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate |
1988-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff13e1e37a79677edabb95d70553032b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7bb4b04da25b760689ffc9a481a907 |
| publicationDate |
1989-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0311651-A1 |
| titleOfInvention |
Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs |
| abstract |
Use of melatonin or related active chemical compounds for the preparation of pharmaceutical compositions for the treatment of stress or acute anxiety as well as for the strengthening of the immune resistance to viral and parasitic infections. |
| priorityDate |
1987-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |